Category: Women’s Health

  • Menopause and Oral Health: What Women and Dentists Need to Know

    Menopause and Oral Health: What Women and Dentists Need to Know

    When we talk about menopause, we tend to focus on hot flushes, sleep, mood and hormones.

    But what about your mouth?

    Bleeding gums, dry mouth, burning sensations and changes in taste can all occur around menopause. Yet these symptoms are rarely part of the conversation.

    And there’s another reason to pay attention. Increasingly, research is revealing connections between oral health and conditions affecting women in midlife, from cardiovascular disease to autoimmune conditions.

    Menopause is an important opportunity to reassess women’s long-term health, and oral health deserves to be part of that conversation.

    For women, that means knowing what to look out for. For dentists, it means recognising the changes, understanding the wider connections and knowing which questions to ask.

    What happens to your mouth during menopause?

    Oestrogen and progesterone influence tissues throughout the body, including those in your mouth.

    Hormonal changes can affect your gums, saliva and oral comfort. However, not every new symptom is caused by menopause. Dental disease, medication, nutritional deficiencies and other medical conditions may also play a role.

    Here are five changes worth recognising.

    1. Dry mouth

    Dry mouth, or xerostomia, is commonly reported during menopause. Saliva helps protect your teeth against decay, neutralises acids and supports swallowing.

    You might notice needing more water, difficulty eating dry foods or waking with a dry mouth. Persistent dryness can increase your risk of cavities and oral infections.

    Medications, diabetes and autoimmune conditions such as Sjögren’s disease can also cause dry mouth, so persistent symptoms deserve assessment.

    2. Bleeding or inflamed gums

    Hormonal changes can influence how your gums respond to dental plaque, potentially increasing inflammation, sensitivity and bleeding.

    But bleeding gums shouldn’t simply be dismissed as hormonal. They may be a sign of gingivitis or periodontal disease and should be checked by your dentist.

    3. Gum disease and changes in the tissues supporting your teeth

    Periodontitis is a chronic inflammatory condition that damages the gums and bone supporting your teeth. It can lead to gum recession, loose teeth and eventually tooth loss.

    Declining oestrogen during menopause may contribute to changes in periodontal health and bone loss, although ageing, smoking, diabetes and oral hygiene also play important roles.

    Menopause doesn’t inevitably cause gum disease, but it’s another good reason to pay attention to your oral health.

    4. Burning mouth symptoms

    Some women experience burning, tingling or discomfort affecting the tongue, lips or other parts of the mouth, particularly after menopause.

    Burning mouth syndrome is diagnosed when persistent symptoms have no identifiable underlying cause. Other explanations, including oral infections, iron or vitamin B12 deficiency, diabetes and medication effects, should be considered first.

    5. Changes in taste and sensitivity

    Some women notice a metallic taste, changes in how food tastes or increased sensitivity to certain foods during menopause.

    These symptoms may be related to hormonal changes, but medications, oral infections and nutritional deficiencies can also be responsible. Persistent or unexplained changes should be investigated.

    Why oral health matters beyond your mouth

    Gum disease is incredibly common. In the latest adult oral health survey in England, 40% of adults with natural teeth had signs of periodontal pocketing.

    Periodontitis is a chronic inflammatory disease of the gums, usually driven by bacteria in dental plaque. It can cause bleeding, deep pockets around the teeth and damage to the tissues and bone that hold them in place. Eventually, teeth may become loose or even be lost.

    But the inflammation doesn’t necessarily stay in your mouth.

    Oral bacteria and their products can enter the bloodstream. So can inflammatory signalling molecules, such as interleukin-6 (IL-6), which are produced as part of the body’s immune response.

    Oral bacteria may also trigger the production of antibodies that circulate around the body. Researchers are investigating whether some of these immune responses could contribute to autoimmune diseases.

    This is why there is growing interest in the links between gum disease and conditions affecting other parts of the body.

    Treating periodontitis can reduce some of these circulating inflammatory signals, including IL-6 and C-reactive protein (CRP). Whether this also prevents other chronic diseases is still being investigated.

    It’s also why we’ve started asking more questions about oral health as part of our health assessments at Coyne Medical. We’ve gone a step further with our Ultimate Health Screening Programme, which now includes oral health screening alongside cardiovascular, metabolic and other aspects of preventative healthcare.

    Menopause, oral health and cardiovascular disease

    The menopausal transition can represent an important turning point in a woman’s cardiovascular risk.

    Cardiovascular disease is the leading cause of death among women worldwide, yet women’s cardiovascular health is still too often overshadowed by conversations about reproductive hormones. Around menopause, women commonly experience changes in cholesterol, body fat distribution, blood pressure and insulin sensitivity.

    What does this have to do with your gums?

    Periodontal disease is linked to an increased risk of cardiovascular disease, including heart attacks and strokes.

    Chronic inflammation and bacteria from the gums may contribute to damage to blood vessels and the development of atherosclerosis. We have even seen oral bacteria show up inside atherosclerotic plaques.

    Treating gum disease has been shown to reduce inflammation in the bloodstream and improve blood vessel function. Whether this translates into fewer heart attacks and strokes is still being studied.

    I would encourage women approaching menopause to know:

    Blood pressure: High blood pressure frequently causes no symptoms, yet it is a major cardiovascular risk factor. But once we diagnose it, we can reduce it to healthy levels.

    Cholesterol and ApoB: LDL cholesterol and ApoB-containing lipoproteins are central to the development of atherosclerosis. Understanding your levels and setting a target is an important part of prevention.

    Lipoprotein(a), or Lp(a): This largely genetically determined cardiovascular risk factor can be elevated even in women who otherwise appear healthy. Most adults should have it measured at least once.

    Blood glucose: Changes in insulin sensitivity and abdominal fat distribution can increase metabolic risk around menopause.

    Family history: Premature cardiovascular disease in close relatives may indicate greater inherited risk.

    Risk assessment should consider lifetime as well as short-term risk, particularly in younger women whose ten-year risk scores may appear reassuring.

    Early menopause and premature ovarian insufficiency are also relevant when assessing cardiovascular risk.

    For women, menopause can be an opportunity to engage with prevention before cardiovascular disease develops.

    For dentists, particularly those treating women with periodontal disease, asking whether a patient has recently had their blood pressure, cholesterol and glucose checked could open an important conversation. Dental professionals do not need to become cardiovascular specialists to help identify someone who might benefit from a medical review.

    Could your mouth be involved in autoimmune disease?

    Women are disproportionately affected by many autoimmune diseases, including rheumatoid arthritis and Sjögren’s disease.

    The relationship between oral health and autoimmunity is particularly interesting because it may involve more than shared inflammation.

    Rheumatoid arthritis: Could the immune response start in the mouth?

    Rheumatoid arthritis is an autoimmune condition affecting joints and sometimes other organs.

    Many people with rheumatoid arthritis have antibodies directed against citrullinated proteins. These are known as anti-citrullinated protein antibodies, or ACPAs. Citrullination is a normal biochemical process that modifies proteins. However, in susceptible people, immune responses to these altered proteins may contribute to autoimmunity.

    One bacterium associated with periodontal disease, Porphyromonas gingivalis, produces an enzyme capable of citrullinating proteins.

    Researchers have proposed that this process could contribute to the formation of antibodies involved in rheumatoid arthritis. Some of these antibodies can appear years before joint symptoms develop. Other oral bacteria and inflammatory processes may also contribute to this complex process.

    Could the mouth be one of the places where rheumatoid arthritis begins?

    It is a fascinating possibility. However, we cannot yet say that periodontal disease causes rheumatoid arthritis or that treating gum disease prevents it.

    Research is exploring whether improving periodontal health could influence autoimmune activity and whether oral inflammation represents a modifiable factor in people at risk. There is also a relationship in the opposite direction. People with rheumatoid arthritis may struggle with brushing and interdental cleaning because of painful or stiff hands, making appropriate dental support particularly important.

    Sjögren’s disease: When dry mouth is more than menopause

    Sjögren’s disease is an autoimmune condition that can damage the glands responsible for producing tears and saliva.

    It disproportionately affects women and frequently presents in midlife.

    Symptoms can include:

    • Persistent dry mouth.
    • Dry or gritty eyes.
    • Difficulty swallowing dry food.
    • Increased dental decay.
    • Fatigue and joint pain.

    Because dry mouth is also reported during menopause, symptoms may initially be attributed to hormonal changes. For dentists, doctors, and patients it’s important we don’t treat dry mouth on it’s own. Thinking about dry eyes and other symptoms is an easy place to start, and it might mean more invesitgations are needed.

    What about Alzheimer’s disease?

    Another emerging area of research concerns periodontal disease and Alzheimer’s disease.

    There are more females living with Alzheimer’s disease than males, partly because women generally live longer. But studies showing those with an early menopause are at higher risk suggest there is also a hormonal element. But we know Alzheimer’s is multifactorial, meaning it is likely to be triggered by a combination of things including genetic prediposition, hormones, cardiovascular risk factors like blood pressure and inflammation.

    Researchers have investigated whether chronic periodontal inflammation and oral bacteria could play a role in neurodegenerative disease.

    Porphyromonas gingivalis has attracted particular attention. Experimental research has explored whether bacterial products, including enzymes called gingipains, may contribute to processes involved in Alzheimer’s disease.

    Observational studies have also reported associations between periodontal disease and dementia. However, these findings do not establish that oral bacteria directly cause Alzheimer’s disease.

    We also need to consider the reverse relationship: people developing cognitive impairment may find maintaining oral hygiene more difficult.

    At present, there is no convincing evidence that treating gum disease prevents Alzheimer’s disease. Nevertheless, the research provides another reason to investigate how oral inflammation might influence health beyond the mouth.

    Is there a connection between oral health and breast cancer?

    Breast cancer is a major concern for many women around menopause. Indeed about 1 in 7 women will be diagnosed in their lifetime so everyone should be aware of it’s risk factors.

    Researchers are investigating whether the oral microbiome, the community of microorganisms living in the mouth, may be associated with breast cancer risk.

    Possible mechanisms include effects on inflammation, immune responses and microbial interactions throughout the body.

    However, the evidence is still preliminary. Studies have produced inconsistent findings, and no oral bacterial pattern has been established as a reliable predictor of breast cancer.

    We cannot currently conclude that improving oral health prevents breast cancer. Established approaches to breast cancer prevention and early detection, including understanding family history, considering inherited genetic risk and appropriate breast screening, remain much more important.

    Not every mouth symptom is menopause: Don’t forget oral cancer

    There is another important reason not to dismiss persistent oral changes as hormonal.

    Mouth cancer is increasing, including among women.

    Cancer Research UK reported in 2016 that oral cancer incidence had increased by 71% over the preceding two decades among women both under and over 50.

    Although these figures come from an older analysis, more recent UK reports continue to highlight rising mouth cancer incidence.

    Oral cancer remains more common in men, but women should not assume they are at low risk.

    Smoking and alcohol are important risk factors. HPV is particularly relevant to cancers arising in the oropharynx, including the tonsils and base of the tongue.

    However, mouth cancer can occur in people without recognised risk factors.

    What symptoms should you look out for?

    Seek assessment from a dentist or doctor for:

    • A mouth ulcer that has not healed within three weeks.
    • A persistent red or white patch.
    • A new lump or swelling in the mouth or neck.
    • Persistent unexplained mouth pain.
    • Difficulty swallowing or speaking.
    • Unexplained numbness or other persistent changes.

    Many of these symptoms have harmless explanations, but they should not be ignored.

    Regular dental examinations provide an opportunity to inspect the soft tissues of the mouth as well as the teeth and gums.

    Persistent symptoms deserve assessment, whether or not you are experiencing menopause.

    Five ways women can protect their oral health during menopause

    1. Don’t ignore bleeding gums

    Bleeding is often a sign of gingival inflammation. Have it assessed rather than assuming hormones are responsible.

    2. Take dry mouth seriously

    Persistent dryness may increase the risk of dental decay and infection.

    Your dentist can recommend protective measures, including appropriate fluoride treatment, saliva substitutes and other strategies. Medical review may be needed to investigate the cause.

    3. Keep up with preventative dental care

    Brush twice daily with fluoride toothpaste and clean between your teeth regularly.

    Your dental team can recommend an appropriate recall interval and periodontal care based on your individual needs.

    4. Tell your dentist about your wider health

    Menopause symptoms, HRT, other medications, diabetes and autoimmune conditions can all be relevant to oral health.

    Your dentist may also identify symptoms that would benefit from medical assessment.

    5. Use menopause as an opportunity to review your overall health

    This is an excellent time to check your cardiovascular risk factors, metabolic health and appropriate cancer screening.

    And don’t forget to include oral health in that conversation.


    Bonus for dentists

    Menopause terminology

    Perimenopause: The years of fluctuating hormones before menopause, when symptoms may begin.

    Menopause: The final menstrual period, confirmed after 12 months without periods.

    Postmenopause: The years following menopause.

    Early menopause: Before age 45.

    Premature ovarian insufficiency: Loss of normal ovarian function before age 40.

    In otherwise healthy women over 45, menopause is usually identified through symptoms and menstrual history rather than hormone blood tests.

    What is HRT?

    HRT usually involves oestrogen, given as a patch, gel, spray or tablet. Women with a uterus generally also need progesterone or another progestogen to protect the womb lining, sometimes provided by a Mirena coil.

    HRT can be started during perimenopause, so taking it doesn’t necessarily mean a woman is postmenopausal.

    There is currently insufficient evidence to recommend HRT specifically for preventing or treating periodontal disease. Not everyone will need or take HRT. It is best used for women with symptoms. Some groups, such as those with a history of breast cancer, may be recommended not to take HRT.

    Six questions worth asking women in midlife

    1. Have you noticed changes in your menstrual cycle or experienced menopause symptoms?

    This may help explain the timing of oral symptoms, although other causes should still be considered.

    2. Are you taking HRT or other medication for menopausal symptoms?

    Understanding hormonal treatment and reviewing other medication may help identify contributors to oral symptoms, particularly dry mouth.

    Remember that women may take HRT during perimenopause as well as after menopause.

    3. Have you experienced dry mouth, burning sensations or changes in taste?

    Women may not volunteer these symptoms unless specifically asked.

    4. Do you experience dry eyes, joint pain or other autoimmune symptoms?

    Persistent dry mouth alongside dry eyes or systemic symptoms may warrant medical assessment, particularly for Sjögren’s disease.

    5. Have you had your blood pressure, cholesterol and blood glucose checked recently?

    The menopausal transition is an important opportunity for cardiovascular prevention.

    Patients with periodontal disease may particularly benefit from understanding their wider cardiovascular and metabolic risk factors.

    6. Have you had an HPV-related condition or received the HPV vaccine?

    Mouth and throat cancer rates have been rising in women. HPV is an important cause of oropharyngeal cancer, and women with cervical HPV infection are more likely to have oral HPV infection.

    A history of cervical HPV doesn’t mean someone will develop mouth or throat cancer, but it’s a useful opportunity to discuss HPV-related cancer risks and the protective benefits of vaccination.

    When should dentists recommend medical assessment?

    Consider medical review for women with:

    • Persistent dry mouth, particularly with dry eyes or joint symptoms.
    • Unexplained oral burning or symptoms suggesting nutritional deficiency, diabetes or autoimmune disease.
    • Menopause symptoms affecting quality of life.
    • Cardiovascular or metabolic risk factors that haven’t been assessed.

    Suspicious oral lesions require appropriate urgent referral.

    Looking beyond the mouth

    Menopause is an important opportunity to reassess women’s long-term health, including cardiovascular, metabolic, bone and oral health.

    For women, that means recognising changes in your mouth and knowing when to seek advice. For dentists, a few additional questions could help identify wider health risks and encourage earlier action.

    Better prevention starts when doctors and dentists look beyond their individual specialties and consider the whole person.

    Learn more about our approach to preventive health screening.

    British Society for Genetic Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in BBC, The Guardian, Women’s Health, The Times and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.


    References

    1. Doughty J, Brookes Z, Liu CC. Women’s oral-hormonal health across the life course: an interdisciplinary challenge. BDJ Team. 2026;13:354–360. https://doi.org/10.1038/s41407-026-3420-9
    2. NICE. Menopause: identification and management (NG23).
    3. American Heart Association. Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention.
    4. European Federation of Periodontology and WONCA Europe. Periodontal disease and systemic health consensus.
    5. Research review on periodontal bacteria and rheumatoid arthritis.
    6. Systematic review of microbiome research in breast cancer.
    7. Cancer Research UK. Mouth cancer rates soar over 20 years.
    8. NHS. Symptoms of mouth cancer.
  • NIPT Test in London: Pregnancy Screening from 10 Weeks

    NIPT Test in London: Pregnancy Screening from 10 Weeks

    Non-invasive prenatal testing (NIPT) is a simple blood test available from 10 weeks of pregnancy. It screens for Down syndrome, Edwards syndrome and Patau syndrome with greater accuracy than traditional first-trimester screening.

    At Coyne Medical in Fulham, London, we offer private NIPT testing through TDL Genetics, with results usually available in 2–4 working days after your sample reaches the laboratory.

    NIPT costs £395, plus a GP consultation (£180 for a standard weekday appointment).

    What is NIPT?

    NIPT stands for non-invasive prenatal testing. It is a blood test that can assess the chance of your baby having certain chromosomal conditions during pregnancy.

    During pregnancy, small fragments of DNA from the placenta circulate in your bloodstream. By analysing this DNA, NIPT can identify pregnancies with a higher or lower probability of specific chromosomal conditions.

    Unlike amniocentesis or chorionic villus sampling (CVS), NIPT only involves taking a blood sample from your arm. There is no risk of miscarriage caused by the blood test itself.

    However, NIPT is a screening test, not a diagnostic test. This means it cannot tell you with certainty whether your baby has a chromosomal condition. If the results shows a high risk further diagnostic tests such as a CVS may be offered.

    What conditions does NIPT screen for?

    The three main conditions screened for are:

    Down syndrome (trisomy 21)

    Down syndrome occurs when a baby has an extra copy of chromosome 21. It is associated with learning disabilities and can be linked to other health conditions, including congenital heart problems. The effects vary considerably between individuals.

    Edwards syndrome (trisomy 18)

    Edwards syndrome is caused by an extra copy of chromosome 18. It is associated with significant developmental and medical complications and is often life-limiting.

    Patau syndrome (trisomy 13)

    Patau syndrome is caused by an extra copy of chromosome 13. It is associated with serious abnormalities affecting the brain, heart and other organs and often has a very poor prognosis.

    Can NIPT test for other conditions?

    The NIPT test used at Coyne Medical can also screen for certain conditions involving the X and Y chromosomes, including:

    • Turner syndrome
    • Klinefelter syndrome
    • Triple X syndrome
    • XYY syndrome

    This additional screening is optional and available at no extra laboratory charge.

    It is also possible to request information about your baby’s sex.

    Screening for sex chromosome conditions is less accurate than screening for the three main trisomies, and your doctor can discuss the benefits and limitations of including it.

    When can you have an NIPT test?

    NIPT can be performed from 10 weeks of pregnancy.

    Before having the test at Coyne Medical, you must have had an ultrasound scan elsewhere to confirm:

    • How many weeks pregnant you are
    • That the pregnancy is viable
    • That you are expecting one baby (a singleton pregnancy)

    If you have not yet had a scan, we can refer you to an appropriate specialist ultrasound service.

    The scan is important because NIPT does not assess your baby’s growth, anatomy or viability.

    How accurate is NIPT?

    NIPT is the most accurate widely used screening test for Down syndrome, Edwards syndrome and Patau syndrome.

    According to performance data provided by our laboratory, TDL Genetics, the test has a reported detection rate of over 99.9% for each of the three main trisomies in the studied screening population. This compares to the standard NHS screening test ‘Combined first trimester screening’, which has a sensitivity of 82%.

    The laboratory also reports specificity greater than 99.9% for these conditions.

    However, these figures do not mean that a positive result gives you a 99.9% chance of having a baby with the condition.

    The likelihood that a positive result is correct depends on several factors, including how common the condition is and your individual circumstances.

    For this reason, it is important to understand the difference between:

    Low probability: The condition is unlikely, but cannot be completely excluded.

    High probability: There is an increased chance of the condition, but further testing is needed for a definitive diagnosis.

    If you receive a high-probability result, your doctor will discuss the next steps, including referral to a fetal medicine specialist.

    What is the difference between NIPT and Harmony?

    Harmony is a brand of NIPT. Different laboratories use different technologies to analyse cell-free DNA during pregnancy.

    At Coyne Medical, we use VeriSeq NIPT Solution v2, an assay manufactured by Illumina and processed by TDL Genetics in London.

    Like Harmony, this test screens for the three main chromosomal trisomies using a maternal blood sample.

    Both are non-invasive prenatal screening tests rather than diagnostic tests.

    If you have been looking for a Harmony test, we can explain the NIPT test available at Coyne Medical and whether it is appropriate for you.

    NIPT versus NHS pregnancy screening

    The NHS offers screening for Down syndrome, Edwards syndrome and Patau syndrome during pregnancy.

    The usual first-trimester combined screening test uses a blood test, an ultrasound measurement and other maternal information to calculate the chance of these conditions.

    NIPT offers greater accuracy and fewer false-positive results than combined first-trimester screening.

    In England, the NHS also offers NIPT as an additional screening option following a higher-chance result from initial NHS screening.

    With private NIPT, you do not need to wait for an NHS higher-chance screening result. You can choose to have the test from 10 weeks.

    Do you still need your NHS pregnancy scans?

    Yes. NIPT cannot detect many structural abnormalities, including neural tube defects, and does not assess fetal growth or wellbeing.

    You should continue with all your recommended NHS antenatal appointments and ultrasound scans, including your routine anomaly scan, even if your NIPT result is low probability.

    How is NIPT performed at Coyne Medical?

    The process is straightforward.

    1. Book a GP appointment

    You can book an appointment with one of our experienced GPs at our clinic in Fulham, London.

    Please ensure you have already had an ultrasound scan confirming your pregnancy dates, viability and that you are expecting one baby. If you have not, we can help arrange a referral.

    2. Discuss your screening options

    Your GP will review your pregnancy history, confirm whether NIPT is suitable and discuss what the test can and cannot tell you.

    You can also decide whether to include optional sex chromosome screening or information about your baby’s sex.

    3. Have your blood test

    A small blood sample is taken from your arm and sent to TDL Genetics for analysis at its London laboratory.

    4. Receive your results

    Results are usually available within 2–4 working days of the laboratory receiving your sample.

    Your GP will communicate your results and explain whether any further investigation is recommended.

    What happens if your NIPT result shows a high probability?

    A high-probability result does not necessarily mean that your baby has the condition.

    Your doctor will discuss the result with you and recommend appropriate further assessment, usually through a fetal medicine specialist.

    Diagnostic testing may involve:

    • Chorionic villus sampling (CVS): Taking a small sample of tissue from the placenta.
    • Amniocentesis: Taking a sample of amniotic fluid to analyse the baby’s chromosomes.

    These procedures can provide a more definitive diagnosis, although they carry a small procedure-related risk of miscarriage.

    It is important that high-probability NIPT results are confirmed through appropriate diagnostic testing before making irreversible decisions about a pregnancy.

    How much does NIPT cost in London?

    At Coyne Medical, our NIPT test costs £295 plus a GP consultation.

    ServicePrice
    NIPT blood test and laboratory analysis£295
    Standard weekday face-to-face GP consultation£180
    Total£475

    You will need to have had an appropriate ultrasound scan before testing. If you require a referral for a scan, this will be arranged separately and the scan provider’s fees will be additional.

    Your GP appointment allows time to discuss the screening options, assess whether the test is suitable and explain what the results may mean.

  • Ziwig Endotest: A Revolutionary Saliva Test for Early Endometriosis Detection

    Ziwig Endotest: A Revolutionary Saliva Test for Early Endometriosis Detection

    Endometriosis is a painful, often life-disrupting condition affecting millions of women worldwide. Despite its prevalence, diagnosis can take years — with the average delay currently over 8 years and 10 months.

    Traditionally, the only definitive way to diagnose endometriosis was through laparoscopy, a surgical procedure under general anaesthetic. But today, a groundbreaking innovation is transforming that reality.

    At Coyne Medical, we are proud to offer the Ziwig Endotest — a non-invasive, saliva-based test developed in France that enables the early detection of endometriosis without the need for surgery. Validated in large-scale clinical trials, with results published in the New England Journal of Medicine in 2023, this test is helping women access faster, safer diagnosis and timely treatment.

    🤍 Understanding Endometriosis: Symptoms, Challenges & the Need for Early Diagnosis

    Endometriosis occurs when tissue similar to the uterine lining grows outside the uterus (womb), often causing:

    • Chronic pelvic pain
    • Heavy or painful periods (dysmenorrhoea)
    • Pain during intercourse (dyspareunia)
    • Digestive symptoms
    • Infertility

    Around 1 in 10 women of reproductive age in the UK are affected, but symptoms often overlap with conditions like IBS (irritable bowel syndrome) or pelvic inflammatory disease, making diagnosis difficult.

    Nearly half of women report 10 or more GP visits before receiving a diagnosis.

    Standard tests such as blood tests, hormone levels, ultrasound, or MRI can often appear normal — leaving patients feeling unheard or doubting their symptoms. The current reliance on laparoscopy delays care and can impact fertility, quality of life, and mental wellbeing.

    🔬 How the Ziwig Endotest® Is Transforming Diagnosis with Non-Invasive Technology

    The Ziwig Endotest® offers a powerful alternative to traditional diagnostic tools:

    • Saliva-based, non-invasive
    • No anaesthetic, no surgery
    • Minimal preparation
    • Results within 3–4 weeks

    In studies across France, the test achieved:

    • 97% sensitivity (correctly identifies 97 out of 100 people with endometriosis)
    • 93% specificity (accurately rules out endometriosis when it’s not present)

    This means women can now receive a reliable diagnosis without undergoing surgery or hospital referral — enabling earlier access to care and treatment.

    🧬 The Science Behind the Ziwig Endotest®

    The test works by detecting over 100 specific microRNA molecules present in saliva — tiny regulators that influence how genes behave in the body. These biomarkers are extracted through Next Generation Sequencing (NGS) and interpreted with advanced artificial intelligence (AI).

    This cutting-edge combination of molecular biology and AI allows the Endotest® to identify even early or subtle signs of endometriosis — even when imaging and blood tests are normal.

    Ziwig is also exploring this technology to diagnose ovarian cancer, fibroids, and other gynaecological conditions.

    👩‍⚕️ What to Expect: Patient Guide to the Ziwig Endotest®

    Step 1: Saliva Collection
    A simple, in-clinic collection of a small saliva sample at your GP consultation.

    Step 2: Laboratory Analysis
    The sample is sent for processing, where RNA biomarkers are analysed using NGS and AI algorithms.

    Step 3: Results
    You’ll receive a report within 3–4 weeks, showing whether the biomarkers linked to endometriosis are present.

    Step 4: Next Steps
    Our GPs will review the results with you and develop a personalised care or referral plan as needed.

    ✅ Who Is the Ziwig Endotest® Suitable For?

    Age range: Women aged 18 to 43 years
    Symptoms:

    • Chronic pelvic pain
    • Painful or heavy periods
    • Pain during sex, urination, or bowel movements
    • Rectal bleeding or shoulder-tip pain during menstruation
    • Difficulty conceiving

    The test can be done at any time during the menstrual cycle, including while taking hormonal treatment.

    ❌ Who Should Not Take the Test?

    • Under 18 or over 43 years of age
    • Current infections (including oral or systemic)
    • History of HIV or cancer

    📊 Comparing Traditional vs. Ziwig Endotest®

    Diagnostic MethodTypeInvasivenessPreparation / RecoveryLimitations
    UltrasoundImagingNon-invasiveMinimal preparationMay miss subtle or deep endometriosis
    MRIImagingNon-invasiveMinimal preparationMay not detect small or early lesions
    LaparoscopySurgical procedureInvasiveRequires anaesthetic and recoveryGold standard, but involves surgical risks
    Ziwig Endotest®Saliva-based testNon-invasiveNo downtime; minimal preparationNew technology; not yet standard NHS practice

    ⏳ How the Ziwig Endotest® Helps Reduce Diagnostic Delays

    The current delay in endometriosis diagnosis causes avoidable distress, prolonged symptoms, and fertility complications.

    By offering an accurate, in-clinic diagnostic test, we can:

    • Shorten time to diagnosis
    • Reduce reliance on surgical procedures
    • Improve early access to treatment
    • Support fertility planning

    ❓ Frequently Asked Questions

    Is the Ziwig Endotest® accurate?
    Yes — it detects 97% of confirmed endometriosis cases and is supported by peer-reviewed research.

    Is it covered by insurance?
    Coverage varies by provider and policy. Please check with your insurer directly.

    Is it painful?
    No — the test is completely non-invasive and pain-free.

    How much does it cost?
    The laboratory test costs £1100, plus a GP consultation (£180) at Coyne Medical.

    How do I access the test?
    Book an appointment with one of our experienced GPs to confirm suitability and begin testing.

    📅 Book Your Ziwig Endotest® Consultation

    If you’re experiencing symptoms such as chronic pelvic pain, painful periods, or difficulty conceiving, early diagnosis is essential.

    Our expert team at Coyne Medical offers personalised support and fast access to the Ziwig Endotest®.
    Book now to explore if this test is right for you.

    👉 Book a GP Consultation Online or call us to schedule your appointment.

    British Society for Genetic Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in BBC, The Guardian, Women’s Health, The Times and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • Menstrual Cycle and Cardiovascular Health: A New Perspective for Women

    Menstrual Cycle and Cardiovascular Health: A New Perspective for Women

    Cardiovascular disease (CVD) remains the leading cause of death and disease for women worldwide. In Western countries, approximately 45% of women aged over 20 years are affected by CVD, and it accounts for one-third of all female deaths. Recognising the unique sex-specific aspects in preventing CVD is crucial as historically, studies in cardiovascular disease have frequently focused on men. Recently, there has been growing interest in studying menstrual cycle characteristics and their potential impact on cardiovascular health. 

    Regular menstrual cycles are a vital sign of women’s overall health, signalling normal functioning of the hypothalamic-pituitary-ovarian axis. However, about 20% of women of reproductive age experience irregular and long menstrual cycles due to endocrine disorders that disrupt this axis. These menstrual irregularities have been linked to several health conditions, including insulin resistance, metabolic disturbances, hyperandrogenism, and chronic inflammation. Consequently, they have been associated with an increased risk of coronary heart disease and related mortality, obesity, and type 2 diabetes.

    To gain further insights into the connection between menstrual cycles and CVD, researchers conducted a large population-based cohort study using data from the UK Biobank. This study included over 58,000 women aged 40 to 69 years who had no pre-existing cardiovascular disease at the study’s outset. Participants were asked to report their current menstrual cycle length and regularity. The researchers followed these women for a median duration of 11.8 years, tracking the development of incident CVD cases through national health records and follow-up visits.

    The study revealed some compelling associations between menstrual cycle characteristics and cardiovascular health. Here are the key findings:

    • Women with irregular menstrual cycles were found to have a 19% higher risk of CVD events, including heart disease and atrial fibrillation, compared to those with regular menstrual cycles.
    • Short (≤21 days) menstrual cycles were associated with a 29% higher risk of CVD events, while long (≥35 days) menstrual cycles showed an 11% increased risk. Specifically, short cycles were linked to a greater risk of coronary heart disease and myocardial infarction.
    • Both short and long menstrual cycles were associated with a higher risk of atrial fibrillation.
    • Interestingly, there was a significant interaction between irregular menstrual cycles and lower high-density lipoprotein cholesterol levels and smoking status, suggesting that these factors might influence CVD risk.

    This study adds to the growing body of evidence suggesting that menstrual cycle characteristics throughout a woman’s reproductive lifespan could be associated with cardiovascular disease. Although the findings are significant, more research is needed to fully understand the underlying mechanisms and establish causality. Future studies are crucial to fill the remaining knowledge gaps and determine on how menstrual cycles might be prospectively linked to cardiovascular disease and subsequent events.

    As we strive to ensure that women’s heart health is finally given the prominent status it deserves, understanding the potential impact of menstrual cycle characteristics on cardiovascular health becomes increasingly vital. The findings from the UK Biobank study provide valuable insights into the associations between irregular, short, and long menstrual cycles and CVD risk in women. Armed with this knowledge, women can take proactive steps towards better cardiovascular health. Regular check-ups, maintaining a healthy lifestyle, and discussing any menstrual irregularities with healthcare professionals can go a long way in safeguarding against CVD. 

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • Are AMH blood tests useful?

    Are AMH blood tests useful?

    Can the AMH blood test tell me if I’m fertile?

    From bus stops to instagram ads for fertility testing appear everywhere. It can feel like a constant wave of information and worry from fertility all the way to menopause. Lots of companies are now offering testing online or at home with promises of giving you information on your fertility. We know it is a worry for many, busy lives often mean women are  having their first babies later than ever. 

    The focus of many ‘fertility’ tests is a hormone called AMH (Anti-Müllerian hormone) in the blood. It is produced by the ovaries. As a woman gets older the levels will naturally decrease. This fit with what we know about ovaries and eggs. Woman are born with all the eggs they will every have. A newborn has over 1 million eggs, by the time of a girl’s first menstrual period that number may be down to 400,000. The number of eggs continues to decline by the average age of natural menopause, around 51 years of age, only about 1000 eggs are likely to remain. As the number of eggs decreases the amount of AMH produces also decreases. 

    So AMH does give an indicator of egg count. It has been used in fertility clinics for many years as it can help the doctor predict response to the medicines used to stimulate egg production in IVF (in-vitro fertilisation). We have excellent data showing that it is a useful test in women who have had fertility problems and are undergoing fertility treatment. 

    It was hoped that it could also be used for other women to predict fertility. A lot of women would like some insight into their fertility. For instance, a common question in the clinic is can I safely delay pregnancy for a few years? 

    Unfortunately, AMH testing can’t help us make that decision. There was a really important study published on this last year, it followed women between the ages of 30 – 44 years. They were screened with an AMH test and then followed for 3 years. There was no difference in fertility between the groups with a low or normal AMH test. This included measuring chance of giving birth to a live baby, and chance of needing fertility treatment. 

    Like most things in medicine there is likely some grey area. It could be that for some women with risk factors for infertility that an AMH level can give some useful information. But that would be just one piece of looking at their fertility and health. 

    Given the low predictive value of AMH testing, I think it is sensible to be cautious before using these tests to make decisions about fertility or life. Choices such as egg freezing or delaying pregnancy can have a big impact on life, finances and relationships. So make sure you are making them with the best science and information. Just like ‘Magic 8 balls’, AMH tests are not recommended to be relied on to predict fertility in healthy women without a history of infertility. 

    British Society for Genetic Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in BBC, The Guardian, Women’s Health, The Times and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • Do you have dense breasts?

    Do you have dense breasts?

    1 in 7 women in the Uk will have breast cancer in their lifetime.

     Those rates are every decade. Knowing your breast density gives you more power to reduce your risk and catch cancers earlier. 

    The more ‘dense’ your breasts are the more likely you are to get breast cancer. About twice as likely as the ‘average’ woman. But it doesn’t end there, increased breast density also makes it much harder to find cancer on a mammogram (x-ray pictures of the breast tissue). 

    Breasts are a mixture of fat cells, glands and fibrous tissue. Fat shows up black on a mammogram (x-ray pictures of the breast tissue). Women with ‘extremely dense’ breasts have very little fat tissue in the breasts, their mammogram pictures look very white. Breast cancer also appears white on mammograms. So looking for cancers in dense breasts has been likened to looking for a white cotton ball in a snowstorm. It is very hard, the detection rate of mammograms can drop to as low as 24%.

    We offer women over 40 years of age a breast density assessment with their annual mammogram screening. Mammograms are the only way to know your breast density. It is not the same as having large breasts or “lumpy” breasts. 

    We offer mammogram screening including breast density assessment to all women over 40. Breast density is categorised from A to D, groups C ‘heterogeneously dense’ and D ‘extremely dense’ are dense breasts. Offering women in groups C and D follow-up MRI or ultrasound scans can detect cancers missed by their mammogram. 

    We know detecting breast cancer early makes them easier to treat and improves long-term survival. 98% will survive over 5 years after a stage 1 breast cancer diagnosis versus only 1 in 4 (26%) diagnosed at stage 4. MRI scanning for women with ‘extremely dense’ breasts has been shown to reduce their risk of dying from breast cancer. 

    Breast density is so important, so if you have a friend or family member so talking about it and raising awareness is vital. In the USA two doctors, JoAnn Pushkin and Wendi Berg both had breast cancer missed on a mammogram, this has driven their campaign to increase awareness and change policy. Now over 40 US states are required by law to inform women of their breast density after their mammogram. In Europe, Cheryl Cruwys also had breast cancer that her mammogram didn’t pick up and is leading the charge to inform women. If you want to read more check their website here.

    British Society for Genetic Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in BBC, The Guardian, Women’s Health, The Times and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • Exercise in Pregnancy Can Increase the Chances of Vaginal Birth

    Exercise in Pregnancy Can Increase the Chances of Vaginal Birth

    A frequent question that we are asked by pregnant mum’s attending the clinic is whether they can continue to exercise during pregnancy. Many of the mums-to-be are worried that exercise may harm the baby or increase the risk of preterm birth. 

    Doctors previously assumed that pregnancy would increase the risk of preterm birth by reducing the blood flow to the placenta which provides vital nutrients to the baby. A recent study set out to check whether exercise in pregnancy really did increase the risk of preterm birth. They carried out a meta-analysis, a study that collects together all the results of previous good quality studies and pools them together. The study only included women who had an uncomplicated, single (i.e. not twin) pregnancy. In total 2059 women were included in the study and, interestingly, all of them were sedentary prior to the studies starting. A wide variety of exercises were tested in the studies including personal training, static cycling, resistance training, swimming, mobilization, and core workouts. 

    The results showed that women who exercised throughout pregnancy doing 35 minutes of exercise 3-4 times per week had no difference in the rate of preterm delivery than those who did no exercise. There was also no difference in birth weight of babies born to mothers who did exercise compared to those who did not. 

    However, women who exercised regularly were more likely to have a vaginal birth and less likely to have a Caesarean Section. In addition, exercise reduces the likelihood of women developing Diabetes in pregnancy or experiencing problems with high blood pressure. 

    So exercise in an uncomplicated pregnancy is not only safe but can also improve chances of vaginal birth and reduce the risk of diabetes and high blood pressure. If you would like to know more about what exercise would suit you in your pregnancy, then contact our team.

    British Society for Genetic Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in BBC, The Guardian, Women’s Health, The Times and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • Breast Ultrasound

    Breast Ultrasound

    When we think about imaging for breasts, typically mammograms come to mind. Yet, ultrasound also has an important role to play and is commonly used. Ultrasound is usually the first-line imaging investigation for women under 40 with symptoms like new breast changes or a lump. In women aged 40 and above, ultrasound is often used in combination with mammography. Think of the two as complementary tests which have different strengths. Some things are better seen on mammography, whilst others are better seen on ultrasound. Ultrasound is particularly good at differentiating between lumps that are solid and cysts containing fluid. Ultrasound is also frequently used to accurately guide procedures in real-time. This includes removing fluid from painful cysts and taking tissue samples from breast lumps.

    Breast density, screening and imaging

    Mammography tends not to be used in younger women because they tend to have “denser” breasts. This means they have a higher proportion of normal fibroglandular tissue. This makes the mammograms look “whiter” and can hide breast pathology which also appears white. It’s a bit like trying to detect a white sticker on the background of a white wall. Your doctor may suggest additional imaging like ultrasound if mammography shows dense breasts. The use of ultrasound for dense breasts and for screening, used in some countries, is a subject of debate. It is important to be aware of the pros and cons to make an informed decision. On one hand, using ultrasound in addition to mammography can increase the chances of picking up a cancer. On the other hand, using ultrasound also increases the likelihood of picking up other benign lesions which may never have caused harm if they were not detected, but once found may need further imaging or a biopsy to confirm a benign diagnosis. So it is worth discussing with your doctor the nuances of this.

    How does it work and what happens during the ultrasound appointment?

    The same technology used to look at babies during pregnancy is used to evaluate the breasts. Unlike other imaging tests which use ionising radiation to generate images, ultrasound uses sound waves that are safe and bounce off the areas of interest to generate images. You will be asked to undress from the waist up and lie down on a couch. The doctor will put gel on a transducer to help the sound waves travel and the transducer will be placed on the skin. An image will be generated on the monitor in real-time and different images will appear as the doctor moves the transducer. The doctor will then review their images and produce a report on their findings.

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • Preventing ACL injuries in Women and Girls

    Preventing ACL injuries in Women and Girls

    ACL injuries are common and can lead to a long time away from playing sport. Recovery can often take 9 months. Having had an ACL injury also increases the risk of having further knee problems down the line. 

    The ACL, or anterior cruciate ligament, is at the front of a pair of ligaments that form a cross. Its role is to prevent the thigh bone (Femur) from sliding too far forward over the shin bone (tibia).

    Why Women and Girls are More Likely to Suffer ACL Injuries

    Women are about 4 times more likely to rupture their ACL than men are. Most ACL tears in women are non-contact injuries that usually occur during an awkward twisting motion. Certain sports have a higher risk of ACL tear. Typically, sports that have rapid stopping or changes in direction, landing from a jump or cutting motions are the highest risk. This includes netball, basketball, football and volleyball. 

    There are several reasons that women and girls are more prone to suffering from ACL injury. Many of these factors, such as female hormones, wider hips and more lax knees cannot be altered. Thus, focusing on preventing ACL injuries has to focus on what we can change.

    Landing Differences

    Two big factors can be changed to help reduce the likelihood of ACL injuries in women and girls. The first is how females tend to land from a jump. Two landing patterns that are particularly risky are landing with stiff, straight legs or landing in a knock-kneed position. These risky landing techniques are more common in women than in men and greatly increase the force through the knees as well as the risk of ACL injury. 

    Hamstrung by Hamstrings

    The second factor that can be altered to reduce ACL injury is what is known as neuromuscular adaptation. This refers to the strength, explosivity, timing and coordination of muscular contraction. Having sufficient strength, as well as being able to engage the right muscle at the right time during movement is crucial for knee stability. The hamstrings are particularly important in knee stability, as like the ACL, they stop the shin bone from sliding too far forward. Females take longer than males to produce force in their hamstrings and contract them more slowly. 

    How To Land Well To Prevent ACL Injuries in Women and Girls

    To land well and reduce the risk of injury observe yourself jumping from a plyometric box or workout step in front of a mirror. Or, ideally, you could also have a partner observe you or film it on your phone. Start and finish the jump with the knees and hips bent. Make sure you keep your knees over and in line with your second toes as you land and that the knees don’t collapse inwards.  Try to land as softly as possible on the front half of the soles of your feet. 

    Strengthening To Prevent ACL Injuries in Women and Girls

    Strengthening hamstrings is really important for ACL prevention. A great exercise for this is Steamboats. Having strong glutes (bum muscles) is also important. They help stop the knees from knocking together. Lateral steps using a theraband and single-leg bridges can be great for this. Stabilising the trunk through core stability exercises such as plank can also help reduce the risk of leg injuries. 

    Plyometric drills such as tuck jumps and squat jumps can help with muscle explosivity and timing or muscle contraction. The core component of these exercises is the squat. it is a foundational move for athletic endeavours. Agility drills such as fast feet can also help improve power and speed while reducing injury risk. 

    If you master these tips, you’ll greatly reduce your risk of ACL injury.

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.

  • The pill, patch or ring? What are my contraceptive options?

    The pill, patch or ring? What are my contraceptive options?

    What are my contraceptive options?

    Most people are familiar with the contraceptive pill or ‘the pill’ as it is better known however there are many other forms of contraception available and more and more people are now availing of these options. There are five types of contraception: hormonal, barrier, intrauterine (inserted inside the uterus/womb), sterilisation and natural. The choice is very much patient driven and the decision should be made after appropriate counselling with an adequately trained healthcare professional.

    The following methods require consistent use to work effectively (user dependent);

    Happy to think more often about your contraception?

    Combined oral contraceptive pills (COCs): These contains 2 different types of hormones (oestrogen & progesterone) and the typical dose is one tablet daily for 21 days and then a ‘pill free week’ where you have a withdrawal bleed/period. There are different choices of oestrogen and progesterone and there are also different strengths of each. The decision of which option to go for depends of a person’s cycle, period flow (heavy/light), age, if there are skin complaints (e.g. acne), mood issues (low mood or PMT (pre-menstrual tension), bleeding issues with other pill options and many other factors.

    Mode of action

    • The synthetic oestrogen stops your body from producing two hormones that are involved in the menstrual cycle: Follicle Stimulating Hormone (FSH) and Luteinising Hormone (LH). This prevents your ovaries from producing an egg because it stops your eggs from ripening and ovulating.
    • The synthetic progesterone thickens the mucus at the entrance of your womb so that sperm can’t get through to fertilise your eggs and also thins the lining of the uterus, making it difficult for a fertilised egg to implant itself.

    Advantages

    • Typical effectiveness* (i.e. prevent pregnancy), perfect effectiveness* 99%.
    • Useful for women who do not want a long term contraceptive method and  are able to comply with the daily medicine schedule.
    • Often reduced bleeding and period pain, and may help with premenstrual symptoms.

    Drawbacks

    • Oestrogen component may not be suitable for some women depending on medical history.
    • May not be suitable for women who could forget to take the pill.
    • Effectiveness can be affected by vomiting or diarrhoea (if severe/persistent) or other medication you are taking.

    Progesterone only pill/POP/’mini pill’: This contains only progesterone of which there are different types available. This pill is taken every day of the cycle/month and there is ‘-no pill free week’.

    Mode of action

    • The majority of mini pills work by thickening the cervical mucus, making it difficult for sperm to get through to fertilise an egg and thinning the lining of the uterus, making it less likely that a fertilised egg will implant itself.
    • Cerazette (desogestrel), the most commonly used mini pill, also works by preventing ovulation.

    Advantages

    • Typical effectiveness 91%*, perfect use effectiveness 99%*.
    • May be suitable for women who do not want to or who cannot take oestrogen e.g. due to medical history.
    • May be used safely in breastfeeding women

    Disadvantages

    • Woman may have changes in menstrual pattern (periods), can cause irregular bleeding/heavier bleeding.
    • Effectiveness can be altered by vomiting/diarrhoea/other medication taken.
    • May not consistently prevent egg release.

    Combined contraceptive patch (CCP): Contains both oestrogen & progesterone and mode of action is same as COC pill.

    Advantages

    • Typical effectiveness 91%, perfect use effectiveness 99%*.
    • Patient should apply one patch per week for 3 weeks and then have a patch free week in week 4.
    • Not affected by vomiting or diarrhoea

    Drawbacks

    • May be seen on the skin
    • Oestrogen component may not be suitable for some women depending on medical history.

    Vaginal ring: Flexible ring which is placed inside the vagina and contains both oestrogen and progesterone. Similar mode of action as COC and CCP.

    Advantages

    • Typical effectiveness 91%, perfect use effectiveness 99%*.
    • Only needs to be replaced once per month (one week following removal (ring free week)).
    • Not affected by vomiting or diarrhoea

    Drawbacks

    • Need to learn how to insert (via trained individual)
    • Oestrogen component may not be suitable for some women depending on medical history.

    Condoms: Male & female, acts as barrier, does not contain any hormones and use is not restricted due to medical history.

    Advantages

    • Typical effectiveness for male is ~82%; perfect use effectiveness is ~98%*.
    • Typical effectiveness for female is ~79%; perfect use effectiveness is ~95%.
    • May be useful for those who wish to avoid hormones, or as additional protection.
    • The only contraception that offers protection against sexually transmitted infections.

    Drawbacks

    • Putting them on can involve interruption of sexual intercourse.
    • The male condom can split or rupture.
    • The female condom can be accidentally dislodged.

    Diaphragm & caps: Barrier method that fits inside the vagina, does not contain hormones and use is not restricted to your medical history.

    Advantages

    • Typical effectiveness 71-88%*; perfect use effectiveness (when used with       spermicide) ~92-96%*.
    • For women who do not want a long term contraception method but who wish to avoid taking hormones.

    Drawbacks

    • Can take time to learn how to use
    • Involves forward planning or interruption of intercourse.
    • Can be messy as you need to use spermicide as well.

    Natural methods: Recognising the fertile and infertile times of your cycle to plan when you should avoid intercourse.

    Advantages

    • Efficacy will vary depending on the type of NFP method used, if/how many methods used concurrently and how reliably it is adhered to; typical effectiveness ~76%*, perfect effectiveness can be between 91-99%*.
    • May be useful for those who wish to avoid hormones or devices.
    • Can be used at all stages of reproductive life.

    Drawbacks

    • There are different types of NFP methods and it can take up to 6 months to learn effectivity
    • Stress or illness can make the method unreliable.
    • Need to avoid intercourse at certain times of the month and be highly motivated.
    • Does not protect against sexually transmitted infection

    For further information:
    https://patient.info/health/contraception-methods/natural-family-planning-methods

    Don’t want to think about contraception everyday/every time you have sex?

    Then why don’t you consider Long Acing Reversible Contraceptive methods (LARC).

    IUD/intrauterine device: Copper containing coil inserted into the womb and can remain in place for 5-10 years (depending on type used), does not contain hormones so does not interact with other medications.

    Mode of action

    The copper released makes the uterus an in-hospitable environment for sperm.

    Advantages

    • Typical & perfect use effectiveness is over 99%*->user independent.
    • For women who want longer-term contraception but do not want hormones.
    • Fertility should return to levels expected for you after removal.
    • May be used safely in breastfeeding women

    Drawbacks

    • Women may have changes in menstrual patterns (periods).
    • Insertion and removal must be performed by trained healthcare professional

    IUS/intrauterine system/better known as Mirena coil: Progesterone containing coil/device fitted into womb and can last 3 or 5 years depending on type used.

    Mode of action

    • Progesterone is released daily and essentially works by preventing fertilization.

    Advantages

    • Typical & perfect use effectiveness is over 99%*-> user independent.
    • Fertility should return to levels expected for you after removal.
    • Can greatly help with patients with heavy periods.
    • May be used safely in breastfeeding women

    Drawbacks

    • Some women may have issues with bleeding.
    • Insertion and removal must be performed by trained healthcare professionals.

    Contraceptive implant: Progesterone containing implant inserted under the skin of the upper arm which lasts for up to 3 years.

    Advantages

    • Typical & perfect use effectiveness is over 99%*-> user independent.
    • Fertility should return to levels expected for you after removal.
    • May be used safely in breastfeeding women

    Drawbacks

    • Women may have changes in menstrual pattern
    • Insertion and removal must be performed by trained healthcare professionals.

    Contraceptive injection: Progesterone containing injection given every 8-13 weeks, depending on the type used.

    Advantages

    • Typical effectiveness ~94%, perfect use effectiveness ~99%*.
    • Short-term LARC for women and couples awaiting sterilisation or vasectomy.
    • May be used safely in breastfeeding women

    Drawbacks

    • Women may have changes in menstrual patterns
    • Can take time for fertility to return to normal.
    • Can affect bone density

    Want long-term contraception?

    Sterilisation (male & female): Fallopian tubes that carry the egg in women or the vas deferens that carry sperm in the male are cut or clipped.

    Advantages

    • Failure rate is ~1 in 200 or 1 in 500 for females (depending on method) and   1 in 20,000 in males.
    • May be suitable for those who want a permanent method of contraception that involves no hormones.

    Disadvantages

    • Cannot be easily reversed.
    • Involves an operation/procedure.
    • Sterilisation is not effective immediately.

    *’These are ‘typical’ effectiveness rates which is how effective the method is with an average person. Typical rates tend to reflect real life usage (including inconsistent and incorrect use). ‘Perfect’ effectiveness rates is how effective the method is when used perfectly. Refer to the patient information leaflet for ‘perfect use’.

    In conclusion, there is a large variety of contraceptive options available, so please enquire when you are next in with your local GP to see what would best suit you.

    British Association of Sports and Exercise Medicine  ·  European Atherosclerosis Society  · 
    Independent Doctors Federation

    As seen in The Independent, The Daily Mail and Tatler

    For educational purposes. This article is written by a practising GP and is intended to inform, not replace a consultation with your own doctor. It does not constitute medical advice. A note on clinical guidelines: Coyne Medical is an independent private clinic. Our approach is guided by the best available evidence, tailored to each individual. This may go beyond standard NHS or NICE guidance, which is designed for population-level care and weighted by resource constraints.